HIF-1α is a Potential Molecular Target for Herbal Medicine to Tr | DDDT
Ap romising novelt herapeutic approach for the treatment of anemia:... | Download Scientific Diagram
Edgar V. Lerma 🇵🇭 on X: "HIF prolyl hydroxylase inhibitors for the treatment of renal anemia and beyond ca. 2016 from @NatRevNeph #Nephpearls 👉🏼 https://t.co/ay9OS6HsFF https://t.co/4GxsbP3FzS" / X
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
Hif ph inhibitors for anemia in ckd | PPT
Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model | Scientific Reports
Role of Hypoxia-Inducible Factor (HIF) in the Initiation of Cancer and Its Therapeutic Inhibitors | SpringerLink
Small-molecule inhibitors of HIF-PHD2: a valid strategy to renal anemia treatment in clinical therapy - MedChemComm (RSC Publishing)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD - ScienceDirect
Overview of hypoxia-inducible factor (HIF) regulation of... | Download Scientific Diagram
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
The Fight Against Cancer: The Promise of HIF-1 Inhibitors
Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Biomedicines | Free Full-Text | HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Molecules | Free Full-Text | Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model | Scientific Reports
ISN ACT Webinar: Hypoxia inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) - International Society of Nephrology
HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease - ScienceDirect
